Deciphera Pharmaceuticals, Inc. Patent Applications Pending
2 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2017-05-30: Application PCTUS2017035005; Invention USE OF 1-[4-BROMO-5[1-ETHYL-7-(METHYLAMINO)-2 OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL]-2-FLUOROPHENYL]-3-PHENYLUREA AND ANALOGS FOR THE TREATMENT OF CANCERS ASSOCIATED WITH GENETIC ABNORMALITIES IN PLATET DERIVED GROWTH FACTOR RECEPTOR ALPHA; Applicant DECIPHERA PHARMACEUTICALS, INC.; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
- 2017-05-30: Application 62512542; Invention Use of 1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl]-2-fluorophenyl]-3-phenylurea and analogs for the treatment of cancers associated with genetic abnormalities in platelet derived growth factor receptor alpha; Applicant Deciphera Pharmaceuticals, LLC; Status Provisional Application Expired.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2017-05-30 | PCTUS2017035005 | USE OF 1-[4-BROMO-5[1-ETHYL-7-(METHYLAMINO)-2 OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL]-2-FLUOROPHENYL]-3-PHENYLUREA AND ANALOGS FOR THE TREATMENT OF CANCERS ASSOCIATED WITH GENETIC ABNORMALITIES IN PLATET DERIVED GROWTH FACTOR RECEPTOR ALPHA | DECIPHERA PHARMACEUTICALS, INC. | RO PROCESSING COMPLETED-PLACED IN STORAGE | DANIEL L. FLYNN BRYAN D. SMITH OLIVER ROSEN MICHAEL D. KAUFMAN | United States United States United States United States | ||
| 2017-05-30 | 62512542 | Use of 1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl]-2-fluorophenyl]-3-phenylurea and analogs for the treatment of cancers associated with genetic abnormalities in platelet derived growth factor receptor alpha | Deciphera Pharmaceuticals, LLC | Provisional Application Expired | Daniel L. Flynn Michael D. Kaufman Oliver Rosen Bryan D. Smith | United States United States United States United States |